Cargando…

Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin

Periungual warts are commonly resistant to treatment, especially in immunocompromised patients. Many treatment modalities have been used with variable results. Bleomycin is one of the most effective treatments for recalcitrant warts, including the periungual type. It can be used either as a topical...

Descripción completa

Detalles Bibliográficos
Autor principal: Altalhab, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761321/
https://www.ncbi.nlm.nih.gov/pubmed/36545271
http://dx.doi.org/10.4081/dr.2022.9490
_version_ 1784852680335687680
author Altalhab, Saad
author_facet Altalhab, Saad
author_sort Altalhab, Saad
collection PubMed
description Periungual warts are commonly resistant to treatment, especially in immunocompromised patients. Many treatment modalities have been used with variable results. Bleomycin is one of the most effective treatments for recalcitrant warts, including the periungual type. It can be used either as a topical application after needling or as a direct injection. We report complete clearance of multiple periungual warts in an immunocompromised patient after diluted bleomycin injection. The patient did not have a recurrence after eight months of follow up.
format Online
Article
Text
id pubmed-9761321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-97613212022-12-20 Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin Altalhab, Saad Dermatol Reports Case Report Periungual warts are commonly resistant to treatment, especially in immunocompromised patients. Many treatment modalities have been used with variable results. Bleomycin is one of the most effective treatments for recalcitrant warts, including the periungual type. It can be used either as a topical application after needling or as a direct injection. We report complete clearance of multiple periungual warts in an immunocompromised patient after diluted bleomycin injection. The patient did not have a recurrence after eight months of follow up. PAGEPress Publications, Pavia, Italy 2022-11-30 /pmc/articles/PMC9761321/ /pubmed/36545271 http://dx.doi.org/10.4081/dr.2022.9490 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Report
Altalhab, Saad
Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
title Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
title_full Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
title_fullStr Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
title_full_unstemmed Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
title_short Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
title_sort complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761321/
https://www.ncbi.nlm.nih.gov/pubmed/36545271
http://dx.doi.org/10.4081/dr.2022.9490
work_keys_str_mv AT altalhabsaad completeclearanceofperiungualwartsinanimmunocompromisedpatientusingdilutedintralesionalbleomycin